Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | +0.87% | -4.51% | -44.66% |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
25/04 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
Sales 2024 * | 71.1M 76.02M 6.34B | Sales 2025 * | 116M 124M 10.35B | Capitalization | 489M 523M 43.59B |
---|---|---|---|---|---|
Net income 2024 * | -176M -188M -15.7B | Net income 2025 * | -147M -157M -13.11B | EV / Sales 2024 * | 6.87 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | 93.33 99.79 8.32K | EV / Sales 2025 * | 4.21 x |
P/E ratio 2024 * |
-2.6
x | P/E ratio 2025 * |
-2.92
x | Employees | 977 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.57% |
Latest transcript on CureVac N.V.
1 day | +0.87% | ||
1 week | -4.51% | ||
Current month | -23.10% | ||
1 month | -20.75% | ||
3 months | -34.73% | ||
6 months | -56.93% | ||
Current year | -44.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 28/23/28 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 01/16/01 |
Malte Greune
COO | Chief Operating Officer | 59 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 01/19/01 |
Michael Brosnan
BRD | Director/Board Member | 69 | 19/23/19 |
Director/Board Member | 67 | 22/22/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.33 | +0.87% | 837,605 |
25/24/25 | 2.31 | -7.97% | 1,242,504 |
24/24/24 | 2.51 | -3.46% | 1,084,869 |
23/24/23 | 2.6 | +2.77% | 609,966 |
22/24/22 | 2.53 | +3.69% | 598,792 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.66% | 522M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CVAC Stock